Author name: Gary Pepper M.D.

Metabolic Health

The GLP-1 Debate: Separating Hype from Health Benefits

GLP-1 agonists, including medications like Ozempic, Wegovy, and Mounjaro, have gained attention for their weight loss benefits. These drugs mimic the action of the glucagon-like peptide-1 hormone, helping to regulate appetite and blood sugar levels. However, their touted benefits extend beyond weight loss, sparking debates about their broader health impacts.

Aging Metabolism
Metabolic Health

What to Do For An Older Metabolism?

As we get older maintaining our weight tends to get harder. The slowing of our metabolism with time may be part of the reason. How real is that process and at what age does it begin? What kinds of things can be done to reverse a slowing metabolism without using drugs?

Metabolic Health

Metformin: The Diabetes Wonder Drug Hiding in Plain Sight

Metformin has been the mainstay of diabetes treatment for 50 years with an impressive array of success stories in terms of effectiveness and affordability. On top of this, recent research points to the unexpected potential of metformin for the ability to reduce the risk of dementia and cancer and may even slow the aging process. So why is this drug so under-rated? Our review at digs into these intriguing questions.

Metabolic Health, Top 5 Articles

Unmasking the Dark Side of the Ozempic Craze

The craze for Ozempic and related medications for weight loss has come at a great price both economically and possibly health-wise for users of these medications. Major pharmaceutical companies are making billions of dollars of profit while small start up companies offering bootlegged versions of these drugs along with generic drug makers are hoping to join in the bonanza, as well.

Scroll to Top